Coagulation factor concentrates by continuous infusion*
References (40)
- et al.
Acute myocardial infarction in a young hemophilic patient during therapy with factor IX concentrate and epsilon aminokaproic acid
J Pediatr
(1981) - et al.
Treatment of hemophilia B: Serendipitous use of continuous infusion coagulation factor IX
Thromb Res
(1993) Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia
Haemophilia
(1995)- et al.
Biochemical and in vivo properties of high purity factor IX concentrates
Thromb Haemost
(1993) Dose calculation of human factor VIII and factor IX concentrates for infusion therapy
- et al.
Continuous intravenous infusion of factor VIII in classic haemophilia
Br J Haematol
(1970) - et al.
Treatment of anti-factor VIII antibodies
Thromb Haemost
(1977) - et al.
Continuous infusion of factor VIII concentrate for therapy of hemophilia A
Blood
(1981) - et al.
Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia A
Am J Hematol
(1984) - et al.
Continuous infusion of monoclonal antibody-purified factor VIII
Am J Hematol
(1991)
A study of in vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion
Am J Hematol
(1996)
Adjusted dose continuous infusion of factor VIII in patients with haemophilia A
Br J Haematol
(1992)
Monoclonal purified F VIII for continuous infusion: Stability, microbiological safety and clinical experience
Thromb Haemost
(1994)
The feasibility of using concentrates containing factor IX for continuous infusion
Haemophilia
(1995)
Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage
Haemophilia
(1996)
The stability of factor VIII concentrates after reconstitution
Am J Hematol
(1994)
Treatment of haemophilia A by continuous factor VIII infusion
Aust NZ J Med
(1995)
The suitability of recombinant F VIII (Kogenate®) for continuous infusion—stability and bacteriological safety
Br J Haematol
(1994)
Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors
Semin Hematol
(1993)
Feasibility of using recombinant factor VIIa in continuous infusion
Thromb Haemost
(1996)
Cited by (0)
- *
Supported by the Israeli Hemophilia Association.
Copyright © 1997 Published by Elsevier Inc.